James Leal - Nov 29, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
SVP, Operations
Signature
s/ David B. Berger, Attorney-in-Fact for James A. Leal
Stock symbol
TNDM
Transactions as of
Nov 29, 2021
Transactions value $
-$58,551
Form type
4
Date filed
12/1/2021, 06:59 PM
Previous filing
Nov 17, 2021
Next filing
Dec 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +310 +8.05% $0.00 4.16K Nov 29, 2021 Direct
transaction TNDM Common Stock Tax liability -$20K -154 -3.7% $129.66 4.01K Nov 29, 2021 Direct F1
transaction TNDM Common Stock Options Exercise $85.9K +1.67K +41.59% $51.50 5.68K Nov 29, 2021 Direct F2
transaction TNDM Common Stock Options Exercise $19.6K +238 +4.19% $82.34 5.91K Nov 29, 2021 Direct F2
transaction TNDM Common Stock Sale -$161K -1.24K -20.9% $130.64 4.68K Nov 29, 2021 Direct F3, F4
transaction TNDM Common Stock Sale -$87.3K -664 -14.2% $131.54 4.01K Nov 29, 2021 Direct F3, F5
transaction TNDM Common Stock Sale -$665 -5 -0.12% $132.92 4.01K Nov 29, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +310 +11.12% $0.00 3.1K Nov 29, 2021 Common Stock 310 Direct F6, F7, F8
transaction TNDM Stock Option Options Exercise $85.9K +1.67K +7.14% $51.50 25K Nov 29, 2021 Common Stock 1.67K $51.50 Direct F9, F10
transaction TNDM Stock Option Options Exercise $19.6K +238 +3.44% $82.34 7.15K Nov 29, 2021 Common Stock 238 $82.34 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Represents shares of common stock received upon exercise of a stock option award.
F3 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
F4 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $130.19 to $131.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F5 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $131.48 to $132.24.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F6 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F7 Each RSU represents a contingent right to receive one share of common stock of the Company.
F8 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
F9 The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.
F10 The expiration date for these options is 10 years from the date of grant.
F11 The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.